Literature DB >> 9792674

Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding.

L Chakravarty1, L Rogers, T Quach, S Breckenridge, P E Kolattukudy.   

Abstract

Monocytes rolling on the endothelial cell layer interact with monocyte chemoattractant protein-1 (MCP-1) that is tethered to the proteoglycans on the luminal side of the endothelial cells and consequently initiate adhesion of monocytes in the early phase of immune response. The amino acid residues in MCP-1 involved in tethering to the proteoglycans have not been elucidated. MCP-1 showed binding to [3H]heparin with a KD of 1.5 microM. We substituted lysine or histidine residues at the C-terminal end of MCP-1 with alanine residues and tested these mutants for their ability to bind heparin, heparan sulfate, hyaluronic acid, and chondroitin sulfate-C. Substitution of Lys-58 or His-66 drastically reduced glycosaminoglycan binding. Substitution of Lys-56 or deletion of the five amino acid residues at the C terminus, including Lys-75, did not alter the heparin binding ability, suggesting that the other lysine residues at the C terminus are not involved in glycosaminoglycan binding. MCP-1 and its mutants did not bind hyaluronic acid as strongly as the other subunits of the GAGs. Substitution of Lys-58 or His-66 by alanine that prevented glycosaminoglycan binding did not affect Ca2+ influx, receptor binding, or chemotactic activity elicited by the chemokine on monocytic THP-1 cells. Therefore, we conclude that the Lys-58 and His-66 residues in the C-terminal alpha-helix of MCP-1 are essential for glycosaminoglycan binding and probably for the binding to the endothelial surface proteoglycans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792674     DOI: 10.1074/jbc.273.45.29641

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.

Authors:  Matthew Ndonwi; Oname O Burlingame; Aaron S Miller; Douglas M Tollefsen; George J Broze; Daniel E Goldberg
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

2.  Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.

Authors:  T I Arefieva; T L Krasnikova; A V Potekhina; N U Ruleva; P I Nikitin; T I Ksenevich; B G Gorshkov; M V Sidorova; Zh D Bespalova; N B Kukhtina; S I Provatorov; E A Noeva; E I Chazov
Journal:  Inflamm Res       Date:  2011-07-10       Impact factor: 4.575

3.  Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil clearance.

Authors:  Ping Li; Gabriela E Garcia; Yiyang Xia; Wei Wu; Christine Gersch; Pyong Woo Park; Luan Truong; Curtis B Wilson; Richard Johnson; Lili Feng
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

5.  Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor.

Authors:  Jennifer M Alexander-Brett; Daved H Fremont
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

6.  Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.

Authors:  Amita Datta; Martin J Stone
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

7.  Inhibition of migration of monocytes and granulocytes in vivo by the peptide corresponding to sequence 65-76 of monocyte chemotactic protein-1 (MCP-1).

Authors:  E I Chazov; T L Krasnikova; Z D Bespalova; N B Kukhtina; M G Melekhov; T I Aref'eva; M V Sidorova; A S Molokoedov; T E Gvozdik; B M Mart'yanov; V V Pozdeev; V B Sergienko; T L Bushueva
Journal:  Dokl Biochem Biophys       Date:  2006 Nov-Dec       Impact factor: 0.788

8.  Establishment and characterization of a new human first trimester Trophoblast cell line, AL07.

Authors:  Hong Liu; Liling Wang; Yan Wang; Qian Zhu; Paulomi Aldo; Jiahui Ding; Gil Mor; Aihua Liao
Journal:  Placenta       Date:  2020-08-21       Impact factor: 3.481

9.  Affinity-based microdialysis sampling using heparin for in vitro collection of human cytokines.

Authors:  Yuexi Wang; Julie A Stenken
Journal:  Anal Chim Acta       Date:  2009-08-14       Impact factor: 6.558

Review 10.  Monocyte-mediated defense against microbial pathogens.

Authors:  Natalya V Serbina; Ting Jia; Tobias M Hohl; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.